Semaglutide Microdosing: Low-Dose GLP-1 Research
Semaglutide microdosing explores low GLP-1 doses for weight loss, aiming to reduce misuse risks. Research is nascent, with no consensus on efficacy or
Research Blog
Semaglutide for Alcohol Use Disorder: What the VA Trial Means for GLP-1 Weight Loss Patients
The VA trial testing semaglutide for alcohol use disorder could reshape understanding of GLP-1 drugs. This article examines the research, misconceptions
View Latest Post